Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
9663810
Reference Type
Journal Article
Title
Second primary cancer in patients with papillary thyroid carcinoma
Author(s)
Zafon, C; Obiols, G; Mesa, J
Year
2013
Is Peer Reviewed?
Yes
Journal
Anticancer Research
ISSN:
0250-7005
EISSN:
1791-7530
Volume
33
Issue
1
Page Numbers
337-340
Language
English
PMID
23267166
Abstract
BACKGROUND AND AIM:
There is an increased incidence of secondary primary cancer (SPC) in patients with papillary thyroid carcinoma (PTC). The risk is stronger in the first year after the first malignancy (synchronous tumours). The aim of this study was to assess the prevalence of SPC in patients with PTC, and to analyse whether the timing of tumour presentation influenced the clinicopathological characteristics of PTC.
PATIENTS AND METHODS:
A total of 184 patients with PTC were included in the study.
RESULTS:
There were 24 patients with SPC and nine with PTC and two other primary tumours (42 additional malignancies in total). Additional tumours were more prevalent in male and older patients. In 11 cases (33%), the two carcinomas were synchronous. PTCs from synchronous cases were significantly larger than those from non-synchronous cases.
CONCLUSION:
Patients with PTC were at elevated risk for SPC. In one third of patients, both neoplasms were diagnosed within the same year. Male and older patients were more likely to have SPC.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity